Abstract:The nuclear factor κ enhancer binding protein (NF-κB) signalling pathway is important for a range of cellular processes including immune function. Here Xia et al. show that free Lys63 polyubiquitin chains generated, which are not linked to any protein substrates, can directly activate kinases in the NK- κB signalling pathway. Disassembly of the polyubiquitin chains by deubiquitination enzymes prevented kinase activation. These results suggest that unanchored polyubiquitin chains much like second messengers can directly activate kinases in immune and inflammatory pathways. The ubiquitin ligase TRAF6 is essential for the activation of NF-κB and MAP kinases in several signalling pathways important for a range of cellular processes including immune function. TRAF6 functions together with a ubiquitin-conjugating enzyme complex to activate the TAK1 kinase complex downstream, which in turn leads to the activation of NF-κB. Here, by reconstituting TAK1 activation in vitro, free Lys 63 polyubiquitin chains are shown to activate TAK1 directly. TRAF6 is a ubiquitin ligase that is essential for the activation of NF-κB and MAP kinases in several signalling pathways, including those emanating from the interleukin 1 and Toll-like receptors1,2,3. TRAF6 functions together with a ubiquitin-conjugating enzyme complex consisting of UBC13 (also known as UBE2N) and UEV1A (UBE2V1) to catalyse Lys 63-linked polyubiquitination, which activates the TAK1 (also known as MAP3K7) kinase complex4,5. TAK1 in turn phosphorylates and activates IκB kinase (IKK), leading to the activation of NF-κB. Although several proteins are known to be polyubiquitinated in the IL1R and Toll-like receptor pathways, it is not clear whether ubiquitination of any of these proteins is important for TAK1 or IKK activation. By reconstituting TAK1 activation in vitro using purified proteins, here we show that free Lys 63 polyubiquitin chains, which are not conjugated to any target protein, directly activate TAK1 by binding to the ubiquitin receptor TAB2 (also known as MAP3K7IP2). This binding leads to autophosphorylation and activation of TAK1. Furthermore, we found that unanchored polyubiquitin chains synthesized by TRAF6 and UBCH5C (also known as UBE2D3) activate the IKK complex. Disassembly of the polyubiquitin chains by deubiquitination enzymes prevented TAK1 and IKK activation. These results indicate that unanchored polyubiquitin chains directly activate TAK1 and IKK, suggesting a new mechanism of protein kinase regulation.

Reconstitution of the RIG-I Pathway Reveals a Signaling Role of Unanchored Polyubiquitin Chains in Innate Immunity

A Hierarchical Mechanism of RIG-I Ubiquitination Provides Sensitivity, Robustness and Synergy in Antiviral Immune Responses

Unanchored ubiquitin chain sustains RIG-I-induced interferon-I activation and controls selective gene expression

Ube2D3 and Ube2N are essential for RIG-I-mediated MAVS aggregation in antiviral innate immunity

MAVS-loaded unanchored Lys63-linked polyubiquitin chains activate the RIG-I-MAVS signaling cascade

Structural and biochemical studies of RIG-I antiviral signaling

Ordered assembly of the cytosolic RNA-sensing MDA5-MAVS signaling complex via binding to unanchored K63-linked poly-ubiquitin chains

Key role of Ubc5 and lysine-63 polyubiquitination in viral activation of IRF3.

Direct Activation of Protein Kinases by Unanchored Polyubiquitin Chains

Stratified Ubiquitination of RIG-I Creates Robust Immune Response and Induces Selective Gene Expression

Actin cytoskeleton remodeling primes RIG-I-like receptor activation

The Lock-Washer: a Reconciliation of the RIG-I Activation Models

Endosomes serve as signaling platforms for RIG-I ubiquitination and activation

The molecular mechanism of RIG‐I activation and signaling

A Non‐canonical Role of the P97 Complex in RIG‐I Antiviral Signaling

RIG-I Uses an ATPase-Powered Translocation-Throttling Mechanism for Kinetic Proofreading of RNAs and Oligomerization

E3 Ligase FBXW7 is Critical for RIG-I Stabilization During Antiviral Responses

Assembly of the WHIP-TRIM14-PPP6C Mitochondrial Complex Promotes RIG-I-Mediated Antiviral Signaling.

A novel selective autophagy receptor, CCDC50, delivers K63 polyubiquitination-activated RIG-I/MDA5 for degradation during viral infection

K63-linked polyubiquitination of LGP2 by Riplet regulates RIG-I-dependent innate immune response

Phosphorylation-mediated negative regulation of RIG-I antiviral activity